Novo Genomics
Novo Genomics is a Saudi biotech company focused on localizing and applying the latest technologies in genomics / multi-omics, and leveraging data to promote health and wellness. The company leverages innovative Next Generation Sequencing (NGS) technologies to advance solutions from basic research through a preclinical stage to everyday clinical practice, paving the way towards personalized medicine. Novo Genomics' services include clinical genome analysis, bioinformatics consulting, data management, and VarSome for genomic analysis.
Funding 💰
Key people 🧑🤝🧑
- Dr. Abdulelah Alhawsawi - Co-founder & CEO
- Dr. Budoor Almansour - Co-founder & COO
- Ahmed Bokhari - Commercial Director
- Dr. Abdulrahman Alasiri - Biomedical Informatics Director
Highlights ⭐
Content in this section is available for DHArab Premium Members only. We manually enter this information so you can save time researching different companies.
Existing users 👉 click here to login
Looking to become a member? 👉 click here for more information
Video ▶️
In the news 📰
